| Closed |
S0801 |
NON-HODGKIN: Bexxar + CHOP-Rituximab for Advanced Follicular NHL |
4/1/2009 |
12/15/2010 |
100% |
|
|
| Closed |
S0350 |
NON-HODGKIN: PEGS treatment for Peripheral T-Cell NHL |
9/15/2005 |
12/1/2010 |
100% |
|
Published
|
| Closed |
S0520 |
NON-HODGKIN: PXD101 Therapy for B-Cell Lymphoma |
1/1/2006 |
5/1/2009 |
55% |
|
Published
|
| Closed |
S0433 |
NON-HODGKIN: R-CHOP + Bexxar for Advanced Stage Diffuse Large B-Cell Lymphoma |
11/1/2005 |
|
100% |
|
Published
|
| Closed |
S0601 |
NON-HODGKINS: R-CHOP-V followed by VM maintenance therapy for MCL |
8/15/2006 |
6/1/2008 |
100% |
|
Published
|
| Closed |
SWOG-437 |
NSC-409962 ... 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Phase II study ... Advanced Breast Cancer |
1/19/1970 |
|
53% |
|
|
| Open |
S1501 |
Obs Cohort Study of Metastatic HER-2+ BC |
9/15/2017 |
|
72% |
|
|
| Closed |
S0629 |
Observational and Phase II WM w/ Trans. & Maint. for Symptomatic WM |
9/15/2008 |
|
0% |
|
|
| Closed |
S0120 |
Observational MGUS / Asymptomatic Myeloma and Plasma Proliferative Disorders |
6/1/2002 |
4/1/2011 |
97% |
|
Published
|
| Closed |
S1612 |
Older AML |
12/22/2017 |
|
5% |
|
|
| Closed |
S0341 |
OSI-774/PS 2/selected Stage IIIB or IV NSCLC |
9/15/2004 |
10/1/2005 |
100% |
|
Published
|
| Closed |
S9701 |
OVARIAN |
11/15/1997 |
12/1/2001 |
62% |
|
Published
|
| Closed |
S9912 |
OVARIAN |
10/1/2000 |
8/15/2005 |
100% |
|
Published
|
| Closed |
S0009 |
OVARIAN |
3/15/2001 |
2/1/2006 |
100% |
|
Published
|
| Closed |
S0211 |
Ovarian |
4/15/2002 |
1/1/2006 |
77% |
|
Published
|
| Closed |
S0200 |
OVARIAN |
8/15/2002 |
12/15/2004 |
6% |
|
Published
|
| Closed |
S0025 |
OVARIAN |
2/15/2003 |
8/15/2003 |
5% |
|
|
| Closed |
S9700 |
PANCREAS |
9/15/1997 |
6/19/2001 |
90% |
|
Published
|
| Closed |
S9924 |
PANCREAS |
6/1/2000 |
6/1/2001 |
97% |
|
Published
|
| Closed |
S0107 |
PANCREAS |
7/1/2001 |
6/1/2003 |
100% |
|
Published
|
